Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.

DOAC are effective to prevent VTE recurrence in patients with CAT but are associated with an increased risk of bleeding compared to LMWH. The choice of anticoagulant should be personalised, taking into account the patient's bleeding risk, including cancer site, and patient's values and preferences.